Cost effectiveness ratio: an often misunderstood term

Anesth Analg. 1999 May;88(5):1191-2. doi: 10.1097/00000539-199905000-00052.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Droperidol / therapeutic use
  • Health Care Costs*
  • Humans
  • Nausea / prevention & control*
  • Ondansetron / therapeutic use
  • Postoperative Complications / prevention & control*
  • Vomiting / prevention & control*

Substances

  • Ondansetron
  • Droperidol